Analyst Recommendations

1.16 0.02(1.31%)05/17/2024
Akebia Therapeutics Inc. (AKBA)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy2

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades